FDA Approved: FIRDAPSE — Supplemental Application (Catalyst Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for FIRDAPSE (amifampridine phosphate) from Catalyst Pharmaceuticals. The approval indicates a modification or addit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lambert-eaton Myasthenic Syndrome

Drugs mentioned

• FIRDAPSE (AMIFAMPRIDINE PHOSPHATE)

Snippet

SUPPL AP for FIRDAPSE (AMIFAMPRIDINE PHOSPHATE)